SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study

Overview of attention for article published in Cancer Discovery, October 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Dimensions has found 220 publications that cite this research output.

Book chapter (September 2023)

Article in Frontiers of Medicine (September 2023)

Article in Cancers (September 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.